Related Experiment Video
Updated: Apr 15, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
11.6K
Progress in Designing Cytokine Antagonist Antibodies for Cancer Therapy
Henry McEacheron1,2, Giulia Nisita3,2, Peiying Liu1,2
1Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA.
Summary
Therapeutic antibodies targeting cytokines are being developed to treat cancer by modulating immune responses. While promising, complete cytokine blockade may not be ideal, necessitating combination strategies for optimal antitumor immunity.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Cytokines are crucial signaling proteins regulating immune responses and cell fate.
- Dysregulated cytokine activity contributes to cancer development and progression.
- Targeting cytokines is a key strategy for immune-linked disease and cancer therapies.
Purpose of the Study:
- To provide an overview of therapeutic advances in cytokine antagonist antibodies for cancer treatment.
- To discuss the structural and functional characteristics of cytokines in cancer.
- To highlight successes and failures of antibody-based cytokine therapies.
Main Methods:
- Review of preclinical and clinical data on cytokine antagonist antibodies.
- Analysis of cytokine structural and functional roles in oncogenesis.
- Evaluation of therapeutic antibody successes and failures against various cytokines.
Main Results:
- Cytokines like interleukins and chemokines significantly impact cancer progression.
- Therapeutic antibodies targeting cytokines show potential but face challenges.
- Complete cytokine ablation is often undesirable; combination therapies are frequently required.
Conclusions:
- Anti-cytokine antibodies represent a promising class of oncology drugs.
- Understanding complex cytokine functions is vital for effective therapeutic design.
- Innovative approaches and combination strategies will drive future progress in anti-cytokine antibody therapy.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:34Inhibition of Cdk Activity
6.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
02:34Inhibition of CDK Activity
5.7K
5.7K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K